v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
$ in Thousands
Preferred Stock [Member]
Series A 12% Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Deficit [Member]
Total
Beginning balance at Dec. 31, 2023         $ 1,723
Beginning balance (in Shares) at Dec. 31, 2023         176
Ending balance at Jun. 30, 2024         $ 1,723
Ending balance (in Shares) at Jun. 30, 2024         176
Beginning balance at Dec. 31, 2023 $ 500 $ 61 $ 291,847 $ (354,372) $ (61,964)
Beginning balance (in Shares) at Dec. 31, 2023 1,235,000 61,852,914      
Series A 12% convertible preferred stock dividend     30 (30)  
Series A 12% convertible preferred stock dividend (in Shares)   12,350      
Series C super dividend redeemable convertible preferred stock dividend     42 (42)  
Series C super dividend redeemable convertible preferred stock dividend (in Shares)   17,600      
Common stock purchase warrants issued in connection with related party line of credit     537   537
Exercise of common stock options (in Shares)   19,620      
Exercise of common stock purchase warrants   $ 1 375   376
Exercise of common stock purchase warrants (in Shares)   125,093      
Stock-based compensation expense     1,041   1,041
Stock-based compensation expense (in Shares)   250,548      
Net loss       (23,860) (23,860)
Ending balance at Jun. 30, 2024 $ 500 $ 62 293,872 (378,304) (83,870)
Ending balance (in Shares) at Jun. 30, 2024 1,235,000 62,278,125      
Ending balance at Jun. 30, 2024         $ 1,723
Ending balance (in Shares) at Jun. 30, 2024         176
Beginning balance at Mar. 31, 2024 $ 500 $ 59 276,156 (321,094) $ (44,369)
Beginning balance (in Shares) at Mar. 31, 2024 1,235,000 59,582,253      
Series A 12% convertible preferred stock dividend       (38) (38)
Series C super dividend redeemable convertible preferred stock dividend       (26) (26)
Common stock purchase warrants issued in connection with related party line of credit     260   260
Exercise of common stock options (in Shares)   4,898      
Exercise of common stock purchase warrants   $ 1 375   376
Exercise of common stock purchase warrants (in Shares)   125,093      
Stock-based compensation expense     738   738
Net loss       (12,371) (12,371)
Ending balance at Jun. 30, 2024 $ 500 $ 62 293,872 (378,304) (83,870)
Ending balance (in Shares) at Jun. 30, 2024 1,235,000 62,278,125      
Beginning balance at Dec. 31, 2024         $ 1,723
Beginning balance (in Shares) at Dec. 31, 2024         176
Ending balance at Jun. 30, 2025         $ 1,723
Ending balance (in Shares) at Jun. 30, 2025         176
Beginning balance at Dec. 31, 2024 $ 500 $ 62 296,217 (401,572) $ (104,793)
Beginning balance (in Shares) at Dec. 31, 2024 1,235,000 63,157,235      
Series A 12% convertible preferred stock dividend     15 (15)  
Series A 12% convertible preferred stock dividend (in Shares)   12,350      
Series C super dividend redeemable convertible preferred stock dividend     22 (22)  
Series C super dividend redeemable convertible preferred stock dividend (in Shares)   17,600      
Conversion of Series A convertible preferred to common stock $ (10)   10    
Conversion of Series A convertible preferred to common stock (in Shares) (25,000) 4,167      
Common stock purchase warrants issued in connection with related party line of credit     235   235
Exercise of common stock options     724   $ 724
Exercise of common stock options (in Shares)   346,606     346,606
Issuance of common stock     1,218   $ 1,218
Issuance of common stock (in Shares)   417,904      
Stock-based compensation expense   $ 1 877   878
Stock-based compensation expense (in Shares)   104,400      
Net loss       (17,152) (17,152)
Ending balance at Jun. 30, 2025 $ 490 $ 63 299,318 (418,761) (118,890)
Ending balance (in Shares) at Jun. 30, 2025 1,210,000 64,060,262      
Ending balance at Jun. 30, 2025         $ 1,723
Ending balance (in Shares) at Jun. 30, 2025         176
Beginning balance at Mar. 31, 2025 $ 500 $ 63 296,631 (411,177) $ (113,984)
Beginning balance (in Shares) at Mar. 31, 2025 1,235,000 63,291,585      
Series A 12% convertible preferred stock dividend       (37) (37)
Series C super dividend redeemable convertible preferred stock dividend       (26) (26)
Conversion of Series A convertible preferred to common stock $ (10)   10    
Conversion of Series A convertible preferred to common stock (in Shares) (25,000) 4,167      
Common stock purchase warrants issued in connection with related party line of credit     235   235
Exercise of common stock options     724   724
Exercise of common stock options (in Shares)   346,606      
Issuance of common stock     1,218   1,218
Issuance of common stock (in Shares)   417,904      
Stock-based compensation expense     500   500
Net loss       (7,521) (7,521)
Ending balance at Jun. 30, 2025 $ 490 $ 63 $ 299,318 $ (418,761) $ (118,890)
Ending balance (in Shares) at Jun. 30, 2025 1,210,000 64,060,262